Conversa, a San Francisco, CA-based healthcare conversation platform used for improving the doctor – patient relationship, secured $8M in Series A funding.
The round was led by Northwell Ventures, the corporate venture arm of Northwell Health, with participation from Epic Ventures, Healthgrades, and current investors. In conjunction with the funding, Conversa also expanded its Board of Directors with the addition of Northwell Health Solutions’ Executive Director, Joseph Schulman and Steven Lindseth, serial entrepreneur and advisor to several academic medical centers and Triple Tree Capital Partners.
The company intends to use the funds to expand its product capabilities and clinical conversation library, enhance its customer and distribution partner operations, and scale its team.
Led by West Shell III, CEO and co-founder, Conversa provides the Conversa Conversation Platform™, which aims to improve how patients and care teams communicate around key health experiences like chronic condition management, post discharge, pre- and post-surgery, patient education, medication adherence, scheduling appointments, and lifestyle health coaching by delivering smart, automated and patient profile-driven conversations.
Sourcing from more than 400 biometric devices combined with clinical, claims and patient-generated data, providers receive data in real-time for more informed allocation of resources and ongoing adjustments to care and treatment plans as needed.
Conversa is being adopted by health systems including Northwell, Ochsner Health System, Citrus Valley Health Partners, and Centura Health’s Penrose St. Francis.